Tag: pharmaceutical competition
Patent Litigation: How Authorized Generics Undermine Generic Competition
Authorized generics let brand drugmakers launch their own versions during the first generic's exclusivity period, slashing revenues and discouraging patent challenges. Here's how this legal loophole hurts competition and patients.
read morerecent posts
Minocycline is a common antibiotic for acne, but it comes with risks like dizziness and skin discoloration. Learn how doxycycline, tetracycline, and other alternatives compare in effectiveness, cost, and safety.
Published ON: 18 NovGeneric drugs save billions annually but trigger massive revenue losses for brand manufacturers when patents expire. Learn how patent cliffs, pay-for-delay deals, and PBM practices shape the hidden economics of prescription drugs.
Published ON: 25 NovNot all pills can be safely split. Learn which medications are safe to split, which ones are dangerous, and how to do it correctly to avoid overdose or reduced effectiveness.
Published ON: 9 NovFluoroquinolone antibiotics like ciprofloxacin and levofloxacin can cause sudden tendon rupture, especially in older adults and those taking steroids. Know the signs, risks, and safer alternatives.
Published ON: 24 NovLearn how low-income seniors can qualify for the Extra Help Program to cut prescription drug costs by up to 83%. Get the 2025 income limits, application steps, and hidden benefits like $0 insulin copays.
Published ON: 28 Nov